Oncology Voice Network
Join to access to all OVN content. Join for Free
Season 2, Episode 20: Exploring The ProFound with John Lepore

Season 2, Episode 20: Exploring The ProFound with John Lepore

  • Oct 13th 2025
  • 22 mins
  • The Pharmaverse Podcast

Share This Article

Summary

Join host Michael Pietrack on The Pharmaverse Podcast as he talks with John Lepore, CEO of ProFound Therapeutics, about leadership, career pivots, and the future of pharmaceutical innovation. Discover how passion, mentorship, and strategic partnerships drive breakthrough therapies and impact patient care.

In this episode:

👉Explore ProFound Therapeutics' innovative approach to discovering novel proteins and therapies.

👉Learn leadership lessons for small companies vs. large corporations.

👉Gain insights into career management, mentorship, and taking calculated risks.

👉Hear inspiring stories on how science, focus, and urgency shape breakthroughs.

👉Understand the importance of company culture, accountability, and collaboration in the pharmaceutical industry.

📌 Don’t forget to subscribe for more insights from leaders shaping the future of pharma and healthcare innovation.

Watch on YouTube

Related Topics

See More Topics

Meet Our Innovation Partners

You May Also Like

Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
OVN Avatar E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Sep 21st • 3 mins • read
Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Mar 30th • 47 mins • listen
Article
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
OVN Avatar Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Jan 7th • 8 mins • read
Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Dec 20th • 15 mins • read
Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Jun 18th • 30 mins • read
Article
Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved
OVN Avatar Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD

Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved

Apr 1st • 14 mins • read

Explore OVN

Articles Expert-written insights
Browse Topics Oncology focus areas
OVN Podcast Flagship show
Community Why join OVN